DelveInsight’s “Atherosclerotic Cardiovascular Disease Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Atherosclerotic Cardiovascular Disease, historical and forecasted epidemiology as well as the Atherosclerotic Cardiovascular Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Atherosclerotic Cardiovascular Disease market report provides current treatment practices, emerging drugs, Atherosclerotic Cardiovascular Disease market share of the individual therapies, current and forecasted Atherosclerotic Cardiovascular Disease market Size from 2019 to 2032 segmented by seven major markets. The Report also covers current Atherosclerotic Cardiovascular Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the Atherosclerotic Cardiovascular Disease market.
Some of the key facts of the Atherosclerotic Cardiovascular Disease Market: Report
The number of patients with Atherosclerotic Cardiovascular Disease was 4,073,832 in 2014 and 4,235,437 in 2015.
Approximately 60% of these patients were incident patients in both years. The number of patients with the disease was slightly higher in women than in men. When we excluded the patients with Atherosclerotic Cardiovascular Disease in the previous year in these groups, the numbers of patients at high risk for Atherosclerotic Cardiovascular Disease in 2015 were estimated as follows: 4,189,371 (diabetes mellitus), 7,349,810 (hypertension), and 7,809,475 (dyslipidemia)
Got queries? Click here to know more about the Atherosclerotic Cardiovascular Disease Market Landscape
Atherosclerotic Cardiovascular Disease Overview
Atherosclerosis is a pattern of the disease arteriosclerosis in which the wall of the artery develops abnormalities, called lesions. These lesions may lead to narrowing due to the buildup of atheromatous plaque. At the onset, there are usually no symptoms, but if they develop, symptoms generally begin around middle age. When severe, it can result in coronary artery disease, stroke, peripheral artery disease, or kidney problems, depending on which arteries are affected. The exact cause is not known and is proposed to be multifactorial. Risk factors include abnormal cholesterol levels, elevated levels of inflammatory markers, high blood pressure, diabetes, smoking, obesity, family history, genetics, and an unhealthy diet. Plaque is made up of fat, cholesterol, calcium, and other substances found in the blood. The narrowing of arteries limits the flow of oxygen-rich blood to parts of the body. Diagnosis is based on a physical exam, electrocardiogram, and exercise stress test, among others.
Atherosclerotic Cardiovascular Disease Epidemiology Insights
Patients aged over 18 years with Atherosclerotic Cardiovascular Disease were selected from January 1, 2014, to December 31, 2015, and those at high risk for Atherosclerotic Cardiovascular Disease were selected from January 1, 2015, to December 31, 2015. The intake period of patients at high risk for Atherosclerotic Cardiovascular Disease was set to 1 year. All patients with at least 1 diagnosis, medication, or procedure code related to Atherosclerotic Cardiovascular Disease, or a risk factor for Atherosclerotic Cardiovascular Disease were identified.
Atherosclerotic Cardiovascular Disease Epidemiology Segmentation
Total Atherosclerotic Cardiovascular Disease prevalent cases
Total Atherosclerotic Cardiovascular Disease age-specific cases
Total Atherosclerotic Cardiovascular Disease treatment-specific cases
Total Atherosclerotic Cardiovascular Disease diagnosed in specific cases
Atherosclerotic Cardiovascular Disease Market Outlook
The Atherosclerotic Cardiovascular Disease market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Atherosclerotic Cardiovascular Disease market trends by analyzing the impact of current Atherosclerotic Cardiovascular Disease therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Atherosclerotic Cardiovascular Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Atherosclerotic Cardiovascular Disease market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Atherosclerotic Cardiovascular Disease market in 7MM is expected to witness a major change in the study period 2019-2032.
Learn more by requesting for sample @ Atherosclerotic Cardiovascular Disease Market Trends
Atherosclerotic Cardiovascular Disease Key Companies
Genentech
Amgen
Bayer
Novartis
Takeda
And many others
Atherosclerotic Cardiovascular Disease Therapies
Rivaroxaban
Inclisirian
Olphasirian
Alirocumab
Glipizide
Table of Contents
Key Insights
Report Introduction
Executive Summary of Atherosclerotic Cardiovascular Disease
Disease Background and Overview
Epidemiology and patient population
The United States
EU 5
Atherosclerotic Cardiovascular Disease Emerging Therapies
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Atherosclerotic Cardiovascular Disease Report Methodology
DelveInsight Capabilities
Disclaimer
Click here to read more about Atherosclerotic Cardiovascular Disease Market
Media ContactCompany Name: DelveInsight Business ResearchContact Person: Adya KaulEmail: Send EmailPhone: 8774225362Address:27 Drydock Ave S. Jones Blvd #2432City: BostonState: MACountry: United StatesWebsite: https://www.delveinsight.com/
